Ilomedin Treatment for Patients Having Undergone Primary Percutaneous Coronary Intervention (PCI)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
Acute myocardial infarct patients with STEMI (ST-elevation on ECG) whom undergo a primary percutaneous cardiac intervention will following the standard treatment , received low dose of Ilomedin and to low dose of standard treatment for another 24 hours.
Epistemonikos ID: 7e1df89369495904ec6dcf59597855d7e7dea5c4
First added on: May 05, 2024